Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance.

Michaelsen SR, Staberg M, Pedersen H, Jensen KE, Majewski W, Broholm H, Nedergaard MK, Meulengracht C, Urup T, Villingshøj M, Lukacova S, Skjøth-Rasmussen J, Brennum J, Kjær A, Lassen U, Stockhausen MT, Poulsen HS, Hamerlik P.

Neuro Oncol. 2018 Oct 9;20(11):1462-1474. doi: 10.1093/neuonc/noy103.

2.

Assessing the feasibility of fly based surveillance of wildlife infectious diseases.

Hoffmann C, Stockhausen M, Merkel K, Calvignac-Spencer S, Leendertz FH.

Sci Rep. 2016 Nov 30;6:37952. doi: 10.1038/srep37952.

3.

Combined EGFR- and notch inhibition display additive inhibitory effect on glioblastoma cell viability and glioblastoma-induced endothelial cell sprouting in vitro.

Staberg M, Michaelsen SR, Olsen LS, Nedergaard MK, Villingshøj M, Stockhausen MT, Hamerlik P, Poulsen HS.

Cancer Cell Int. 2016 Apr 26;16:34. doi: 10.1186/s12935-016-0309-2. eCollection 2016.

4.

Comparison of (18)F-FET and (18)F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma.

Nedergaard MK, Michaelsen SR, Perryman L, Erler J, Poulsen HS, Stockhausen MT, Lassen U, Kjaer A.

Nucl Med Biol. 2016 Mar;43(3):198-205. doi: 10.1016/j.nucmedbio.2015.12.002. Epub 2015 Dec 22.

5.

18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastoma.

Nedergaard MK, Michaelsen SR, Urup T, Broholm H, El Ali H, Poulsen HS, Stockhausen MT, Kjaer A, Lassen U.

PLoS One. 2015 Feb 13;10(2):e0115315. doi: 10.1371/journal.pone.0115315. eCollection 2015.

6.

Targeted detection of mammalian species using carrion fly-derived DNA.

Schubert G, Stockhausen M, Hoffmann C, Merkel K, Vigilant L, Leendertz FH, Calvignac-Spencer S.

Mol Ecol Resour. 2015 Mar;15(2):285-94. doi: 10.1111/1755-0998.12306. Epub 2014 Aug 4.

PMID:
25042567
7.

The use of longitudinal 18F-FET MicroPET imaging to evaluate response to irinotecan in orthotopic human glioblastoma multiforme xenografts.

Nedergaard MK, Kristoffersen K, Michaelsen SR, Madsen J, Poulsen HS, Stockhausen MT, Lassen U, Kjaer A.

PLoS One. 2014 Jun 11;9(2):e100009. doi: 10.1371/journal.pone.0100009. eCollection 2014.

8.

Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.

Kristoffersen K, Nedergaard MK, Villingshøj M, Borup R, Broholm H, Kjær A, Poulsen HS, Stockhausen MT.

Cancer Biol Ther. 2014 Jul;15(7):862-77. doi: 10.4161/cbt.28876. Epub 2014 Apr 22.

9.

Differentiation of glioblastoma multiforme stem-like cells leads to downregulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potential.

Stockhausen MT, Kristoffersen K, Stobbe L, Poulsen HS.

Cancer Biol Ther. 2014 Feb;15(2):216-24. doi: 10.4161/cbt.26736. Epub 2013 Nov 1.

10.

Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution.

Michaelsen SR, Christensen IJ, Grunnet K, Stockhausen MT, Broholm H, Kosteljanetz M, Poulsen HS.

BMC Cancer. 2013 Sep 3;13:402. doi: 10.1186/1471-2407-13-402.

11.

Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures.

Kristoffersen K, Villingshøj M, Poulsen HS, Stockhausen MT.

Cancer Biol Ther. 2013 Jul;14(7):625-37. doi: 10.4161/cbt.24595. Epub 2013 May 10.

12.

Notch signaling and brain tumors.

Stockhausen MT, Kristoffersen K, Poulsen HS.

Adv Exp Med Biol. 2012;727:289-304. doi: 10.1007/978-1-4614-0899-4_22. Review.

PMID:
22399356
13.

Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer.

Denholt CL, Binderup T, Stockhausen MT, Poulsen HS, Spang-Thomsen M, Hansen PR, Gillings N, Kjær A.

Nucl Med Biol. 2011 May;38(4):509-15. doi: 10.1016/j.nucmedbio.2010.11.003. Epub 2011 Mar 1.

PMID:
21531288
14.

Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme.

Stockhausen MT, Broholm H, Villingshøj M, Kirchhoff M, Gerdes T, Kristoffersen K, Kosteljanetz M, Spang-Thomsen M, Poulsen HS.

Exp Cell Res. 2011 Jul 1;317(11):1513-26. doi: 10.1016/j.yexcr.2011.04.001. Epub 2011 Apr 15.

PMID:
21514294
15.

Irinotecan and bevacizumab in recurrent glioblastoma multiforme.

Jakobsen JN, Hasselbalch B, Stockhausen MT, Lassen U, Poulsen HS.

Expert Opin Pharmacother. 2011 Apr;12(5):825-33. doi: 10.1517/14656566.2011.566558. Epub 2011 Mar 9. Review.

PMID:
21385110
16.

Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan.

Hasselbalch B, Eriksen JG, Broholm H, Christensen IJ, Grunnet K, Horsman MR, Poulsen HS, Stockhausen MT, Lassen U.

APMIS. 2010 Aug;118(8):585-94. doi: 10.1111/j.1600-0463.2010.02631.x.

PMID:
20666740
17.

Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas.

Bartkova J, Hamerlik P, Stockhausen MT, Ehrmann J, Hlobilkova A, Laursen H, Kalita O, Kolar Z, Poulsen HS, Broholm H, Lukas J, Bartek J.

Oncogene. 2010 Sep 9;29(36):5095-102. doi: 10.1038/onc.2010.249. Epub 2010 Jun 28.

PMID:
20581868
18.

Cetuximab insufficiently inhibits glioma cell growth due to persistent EGFR downstream signaling.

Hasselbalch B, Lassen U, Poulsen HS, Stockhausen MT.

Cancer Invest. 2010 Oct;28(8):775-87. doi: 10.3109/07357907.2010.483506.

PMID:
20504227
19.

Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial.

Hasselbalch B, Lassen U, Hansen S, Holmberg M, Sørensen M, Kosteljanetz M, Broholm H, Stockhausen MT, Poulsen HS.

Neuro Oncol. 2010 May;12(5):508-16. doi: 10.1093/neuonc/nop063. Epub 2010 Feb 5.

20.

The functional role of Notch signaling in human gliomas.

Stockhausen MT, Kristoffersen K, Poulsen HS.

Neuro Oncol. 2010 Feb;12(2):199-211. doi: 10.1093/neuonc/nop022. Epub 2009 Dec 14. Review.

21.

Cell adhesion and EGFR activation regulate EphA2 expression in cancer.

Larsen AB, Stockhausen MT, Poulsen HS.

Cell Signal. 2010 Apr;22(4):636-44. doi: 10.1016/j.cellsig.2009.11.018. Epub 2009 Dec 2.

PMID:
19948216
22.

Improved response by co-targeting EGFR/EGFRvIII and Src family kinases in human cancer cells.

Andersen P, Villingshøj M, Poulsen HS, Stockhausen MT.

Cancer Invest. 2009 Feb;27(2):178-83. doi: 10.1080/07357900802570759.

PMID:
19235590
23.

EGFR induces expression of IRF-1 via STAT1 and STAT3 activation leading to growth arrest of human cancer cells.

Andersen P, Pedersen MW, Woetmann A, Villingshøj M, Stockhausen MT, Odum N, Poulsen HS.

Int J Cancer. 2008 Jan 15;122(2):342-9.

24.

Mechanisms for oncogenic activation of the epidermal growth factor receptor.

Zandi R, Larsen AB, Andersen P, Stockhausen MT, Poulsen HS.

Cell Signal. 2007 Oct;19(10):2013-23. Epub 2007 Jul 4. Review.

PMID:
17681753
25.

Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility.

Larsen AB, Pedersen MW, Stockhausen MT, Grandal MV, van Deurs B, Poulsen HS.

Mol Cancer Res. 2007 Mar;5(3):283-93.

26.

The Notch pathway in cancer: differentiation gone awry.

Sjölund J, Manetopoulos C, Stockhausen MT, Axelson H.

Eur J Cancer. 2005 Nov;41(17):2620-9. Epub 2005 Oct 18. Review.

PMID:
16239105
27.

Regulation of the Notch target gene Hes-1 by TGFalpha induced Ras/MAPK signaling in human neuroblastoma cells.

Stockhausen MT, Sjölund J, Axelson H.

Exp Cell Res. 2005 Oct 15;310(1):218-28.

PMID:
16120441
28.

Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells.

Stockhausen MT, Sjölund J, Manetopoulos C, Axelson H.

Br J Cancer. 2005 Feb 28;92(4):751-9.

29.
30.

Notch signaling in neuroblastoma.

Påhlman S, Stockhausen MT, Fredlund E, Axelson H.

Semin Cancer Biol. 2004 Oct;14(5):365-73. Review.

PMID:
15288262
31.

[The retinal threshold energy of a short laser impulse (author's transl)].

Hochgesand P, Walther G, Stockhausen M.

Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1973 Oct 19;188(3):183-95. German. No abstract available.

PMID:
4543662
32.

[Determination of retinal dosage limit of short ruby laser impulses in animal experiments].

Hochgesand P, Valeske W, Walther G, Stockhausen M, Leithoff H.

Beitr Gerichtl Med. 1973;31:158-67. German. No abstract available.

PMID:
4797377
33.

[Threshold energy for ocular effects by short laser pulses].

Stockhausen M, Walther G, Hochgesand P.

Int Arch Arbeitsmed. 1972;29(4):340-6. German. No abstract available.

PMID:
5049543

Supplemental Content

Loading ...
Support Center